Leukemic EVs can also regulate T cell responses – EVs released in vivo in mice by AML- patient-derived xenograft (PDX) cells and CML cell lines induced apoptosis of CD8+ effector T cells [141,142]. Here, CD8A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.